Medtronic plc Overview
Pro stress-test →Medtronic plc is the leading global healthcare technology company headquartered in Galway, Ireland, with 95,000+ employees across 150+ countries. The company treats 70 health conditions through cardiac devices, surgical robotics, insulin pumps, surgical tools, and patient monitoring systems, transforming lives of two people every second worldwide.
Strategic Profile
Pro stress-test →The company is experiencing its strongest cardiovascular revenue growth in over a decade, with Cardiac Ablation Solutions revenue increasing 71% on the strength of its pulsed field ablation (PFA) portfolio. Medtronic is close to earning clearance for its Hugo system, a robotic-assisted surgery device, which could help maintain the stock's momentum into 2026. The company is spinning off its diabetes care unit, a strategic move expected to be beneficial as the business has weak margins and faces intense competition.
Competitive Landscape
Pro stress-test →While Medtronic still faces stiff competition in the PFA and Robotics arenas, its diversified portfolio provides a floor that many pure-play competitors lack. In surgical robotics, Medtronic now competes directly with incumbents like Intuitive Surgical in the high-growth soft tissue surgical robotics market. In diabetes care, Medtronic faces competition from Abbott Laboratories' FreeStyle Libre, DexCom's G7, and Tandem Diabetes Care in insulin pumps.
Industry Context
Medtronic plc operates in Medical Devices & Healthcare Technology.
Key facts
Headquarters: Galway, Ireland · Employees: 95000 · Revenue: $34.76B (TTM)